Over 72 weeks, participants without type 2 diabetes achieved the following weight loss results : 5 mg dose: 16.0% average body weight reduction 10 mg dose: 21.4% average body weight reduction 15 mg dose: 22.5% average body weight reduction Placebo: 2.4% average body weight reduction At the highest dose, 92.7% of participants achieved at least 5% weight loss, 84.4% achieved at least 10%, 73.6% achieved at least 15%, 56.1% achieved at least 20%, and 38.7% achieved at least 25% weight loss
10/10 would recommend. Ive been with this program going on 2 months
Speed of Recovery : Anecdotal evidence suggests that BPC 157 users have experienced significantly faster recovery from injuries compared to those not using the peptide, contributing to its popularity among athletes 2
It is a common cause of chronic insidious low back pain, especially in older patient populations (mean age = 64 years)
doi: 10.1038/nn.3062 140 LuH.ZhouQ.HeJ.JiangZ.PengC.TongR.et al
When Not to Use Eflornithine Known hypersensitivity to eflornithine or cream excipients Broken, inflamed, or infected skin in the application area Children ( 6 months: Continue maintenance if satisfied